Amira Pharmaceuticals, Inc San Diego, CA – November 1, 2007- Amira Pharmaceuticals, a small molecule pharmaceutical company focused on the discovery and development of compounds to treat inflammatory disease linked to the eicosanoid pathway, today announced the appointment of Isabelle… Read More
Amira Pharmaceuticals, Inc San Diego, CA – November 1, 20072007 — Amira Pharmaceuticals, Inc. announced completion of the company’s Phase 1 clinical trial of AM103, Amira’s internally discovered oral drug candidate for the treatment of inflammatory diseases linked to the… Read More
Gary Lynch has spent decades trying to understand how the brain processes new information so that we can recall it later.
Gary Lynch’s UC Irvine research team struggles to understand how memories are made. It is crucial to treating age-related declines.
Gary Lynch and his UC Irvine lab team begin to piece together the story of human memory. Then his own brain becomes the focus.
Gary Lynch expects his brain lab’s work to bring ‘all the tribes of neuroscience to the same campfire.’ Instead, he meets resistance.
Matt Hartley With open source software becoming a household name, another open source movement that may one day see some fanfare is already taking shape. Open source hardware, which I once thought to be little more than a pipe dream… Read More
Mark Hendrickson Brooklyn-based Kaltura has earned the honor to present as the 40th company in this year’s TechCrunch40 conference, beating next generation forums provider Tangler by a handful of votes.
Entrepreneur Magazine July 2007 Great news for entrepreneurs last year: Venture capitalists invested $25.5 billion in 3,416 deals in 2006–a 10 percent increase in deal volume and a 12 percent increase in dollar values from 2005, according to the “MoneyTree… Read More
Advertiser Staff The Honolulu Advertiser InCode BioPharmaceutics Inc. in Lahaina received $3 million in venture capital from Avalon Ventures during the second quarter, according to the PriceWaterhouseCoopers Moneytree survey. The company is developing therapeutic compounds to treat autoimmune disorders. Hawaii… Read More
San Diego, CA – Amira Pharmaceuticals, a small molecule pharmaceutical company focused on the discovery and development of compounds to treat inflammatory disease linked to the eicosanoid pathway, today announced that the company has appointed Robert F. Baltera, Jr., as… Read More
San Diego, CA – Amira Pharmaceuticals, a small molecule pharmaceutical company focused on the discovery and development of compounds to treat inflammatory diseases linked to the eicosanoid pathway, today announced initial, positive data from a Phase 1 clinical trial of… Read More
Cambridge biotech trying to mimic breed’s genetics
Woburn, MA – BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today it had raised $22m in the first close of a series E private financing.
Drug Discovery and Development By James Netterwald, PhD, MT (ASCP) Kinases are one of the most important classes of protein in cells. They play a role in cellular signaling, regulating everything from cell growth to inflammation. But, more importantly, when… Read More
By Jan Rasmussen CUPERTINO, Calif. (June 12, 2007) – Vocera Communications, Inc., developers of the Vocera Communications System, the only wearable, hands-free instant voice communication system available on the market, today appointed Robert J. Zollars as Chairman and CEO of… Read More
Venrock, Avalon Ventures and Masthead Venture Partners Support Expansion of Mobile Social Networking Through the ANTHEM Platform and Rabble
Funding Led by Avalon Ventures, Prospect Venture Partners and Versant Ventures